Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Protecting Group Free Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN118271200A enables efficient lacosamide synthesis without protecting groups ensuring supply chain stability and cost reduction for global pharmaceutical manufacturers.
Patent CN118812438A reveals a novel L-carnosine preparation method avoiding protecting groups. Achieves high yield and purity for reliable pharmaceutical intermediate supply chains.